Arrow Mark Colorado Holdings LLC Atreca, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

  • $7.03 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$9.68 - $18.67 $1.75 Million - $3.38 Million
-180,777 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$10.42 - $22.04 $460,803 - $974,674
-44,223 Reduced 19.65%
180,777 $2.21 Million
Q2 2019

Aug 14, 2019
BUY
$17.07 - $18.84 $3.84 Million - $4.24 Million
225,000 New
225,000 $4.24 Million

Others Institutions Holding BCEL

# of Institutions
2
Shares Held
30.6K
Call Options Held
0
Put Options Held
0
View Full List

About Atreca, Inc.

BCEL Quotes by TradingView
  • Ticker BCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,876,000
  • Description
  • Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...
More about BCEL
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email